Cas:70210-17-2 tetrasodium 5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulphonato-1-naphthyl]azo]-2,5-dimethylphenyl]azo]naphthalene-1,3,6-trisulphonate manufacturer & supplier

We serve Chemical Name:tetrasodium 5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulphonato-1-naphthyl]azo]-2,5-dimethylphenyl]azo]naphthalene-1,3,6-trisulphonate CAS:70210-17-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tetrasodium 5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulphonato-1-naphthyl]azo]-2,5-dimethylphenyl]azo]naphthalene-1,3,6-trisulphonate

Chemical Name:tetrasodium 5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulphonato-1-naphthyl]azo]-2,5-dimethylphenyl]azo]naphthalene-1,3,6-trisulphonate
CAS.NO:70210-17-2
Synonyms:1,3,6-Naphthalenetrisulfonic acid,5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulfo-1-naphthalenyl]azo]-2,5-dimethylphenyl]azo]-,tetrasodium salt;5-[[4-[[4-[(4-Amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulfo-1-naphthalenyl] azo]-2,5-dimethylphenyl]azo]-1,3,6-naphthalenetrisulfonic acid,tetrasodium salt;5-[4-[4-(4-Amino-6-chloro-1,3,5-triazin-2-ylamino)-7-(sodiosulfo)-1-naphthalenylazo]-2,5-dimethylphenylazo]-1,3,6-naphthalenetrisulfonic acid trisodium salt;5-[2-[4-[2-[4-[(4-Amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulfo-1-naphthalenyl]diazenyl]-2,5-dimethylphenyl]diazenyl]-1,3,6-naphthalenetrisulfonic acid sodium salt
Molecular Formula:C31H20ClN9Na4O12S4
Molecular Weight:966.21600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:388.48000
Exact Mass:964.93900
LogP:10.19860

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1,3,6-Naphthalenetrisulfonic acid,5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulfo-1-naphthalenyl]azo]-2,5-dimethylphenyl]azo]-,tetrasodium salt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-[2-[4-[2-[4-[(4-Amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulfo-1-naphthalenyl]diazenyl]-2,5-dimethylphenyl]diazenyl]-1,3,6-naphthalenetrisulfonic acid sodium salt physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-[4-[4-(4-Amino-6-chloro-1,3,5-triazin-2-ylamino)-7-(sodiosulfo)-1-naphthalenylazo]-2,5-dimethylphenylazo]-1,3,6-naphthalenetrisulfonic acid trisodium salt Use and application,5-[[4-[[4-[(4-Amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulfo-1-naphthalenyl] azo]-2,5-dimethylphenyl]azo]-1,3,6-naphthalenetrisulfonic acid,tetrasodium salt technical grade,usp/ep/jp grade.


Related News: Saudi Arabia��s state airline and Oman also suspended flights to China on Sunday in reaction to the coronavirus epidemic, according to Reuters. tetrasodium 5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulphonato-1-naphthyl]azo]-2,5-dimethylphenyl]azo]naphthalene-1,3,6-trisulphonate manufacturer INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. tetrasodium 5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulphonato-1-naphthyl]azo]-2,5-dimethylphenyl]azo]naphthalene-1,3,6-trisulphonate supplier The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries. tetrasodium 5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulphonato-1-naphthyl]azo]-2,5-dimethylphenyl]azo]naphthalene-1,3,6-trisulphonate vendor Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). tetrasodium 5-[[4-[[4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-7-sulphonato-1-naphthyl]azo]-2,5-dimethylphenyl]azo]naphthalene-1,3,6-trisulphonate factory Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent).